XML 49 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1
Quarterly Financial Data (Tables)
 12 Months Ended
Dec. 31, 2017
QUARTERLY FINANCIAL DATA (unaudited) [Abstract]  
Quarterly Financial Data
The following table sets forth unaudited consolidated statements of operations data for the eight quarters in the period ended December 31, 2017. This information has been derived from Acacia’s unaudited condensed consolidated financial statements that have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the information when read in conjunction with the audited consolidated financial statements and related notes thereto. Acacia’s quarterly results have been, and may in the future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should not be relied upon as any indication of the results to be expected in any future periods.
 
 
Quarter Ended
 
 
Mar. 31,
 
Jun. 30,
 
Sept. 30,
 
Dec. 31,
 
Mar. 31,
 
Jun. 30,
 
Sept. 30,
 
Dec. 31,
 
 
2017
 
2017
 
2017
 
2017
 
2016
 
2016
 
2016
 
2016
 
 
(Unaudited, in thousands, except share and per share information)
Revenues
 
$
8,854

 
$
16,457

 
$
36,633

 
$
3,458

 
$
24,721

 
$
41,351

 
$
64,658

 
$
21,969

Operating costs and expenses:
 
 

 
 

 
 
 
 
 
 

 
 

 
 

 
 
Cost of revenues:
 
 

 
 

 
 
 
 
 
 

 
 

 
 

 
 
Inventor royalties
 
666

 
4,273

 
—

 
13

 
1,573

 
—

 
17,844

 
3,313

Contingent legal fees
 
627

 
3,236

 
12,173

 
646

 
4,109

 
10,418

 
7,709

 
4,238

Litigation and licensing expenses - patents
 
6,386

 
4,134

 
4,073

 
3,626

 
7,723

 
7,324

 
7,348

 
5,463

Amortization of patents
 
5,515

 
5,571

 
5,625

 
5,443

 
10,760

 
10,759

 
6,467

 
6,222

General and administrative expenses (including non-cash stock compensation expense)
 
6,916

 
6,734

 
12,715

 
(335
)
 
7,994

 
7,535

 
8,334

 
9,056

Other expenses - business development
 
320

 
433

 
241

 
195

 
522

 
1,334

 
666

 
557

Impairment of patent-related intangible assets
 
—

 
—

 
2,248

 
—

 
—

 
40,165

 
—

 
2,175

Other
 
—

 
—

 
—

 
1,200

 
1,742

 
(1,242
)
 
—

 
—

Total operating costs and expenses
 
20,430

 
24,381

 
37,075

 
10,788

 
34,423

 
76,293

 
48,368

 
31,024

Operating income (loss)
 
(11,576
)
 
(7,924
)
 
(442
)
 
(7,330
)
 
(9,702
)
 
(34,942
)
 
16,290

 
(9,055
)
Total other income (expense)
 
696

 
(4,862
)
 
159,027

 
(102,950
)
 
(3
)
 
(52
)
 
261

 
592

Income (loss) before (provision for) benefit from income taxes
 
(10,880
)
 
(12,786
)
 
158,585

 
(110,280
)
 
(9,705
)
 
(34,994
)
 
16,551

 
(8,463
)
Provision for income taxes
 
(1,241
)
 
(1,478
)
 
(216
)
 
(20
)
 
(192
)
 
(5,927
)
 
(9,655
)
 
(2,414
)
Net income (loss) including noncontrolling interests
 
(12,121
)
 
(14,264
)
 
158,369

 
(110,300
)
 
(9,897
)
 
(40,921
)
 
6,896

 
(10,877
)
Net (income) loss attributable to noncontrolling interests in subsidiaries
 
291

 
12

 
96

 
97

 
(68
)
 
348

 
186

 
266

Net income (loss) attributable to Acacia Research Corporation
 
$
(11,830
)
 
$
(14,252
)
 
$
158,465

 
$
(110,203
)
 
$
(9,965
)
 
$
(40,573
)
 
$
7,082

 
$
(10,611
)
Net income (loss) per common share attributable to Acacia Research Corporation:
 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Basic and diluted income (loss) per share
 
$
(0.24
)
 
$
(0.28
)
 
$
3.13

 
$
(2.18
)
 
$
(0.20
)
 
$
(0.81
)
 
$
0.14

 
$
(0.21
)
Weighted-average number of shares outstanding, basic
 
50,333,056

 
50,499,948

 
50,554,234

 
50,590,460

 
49,925,550

 
50,015,869

 
50,124,302

 
50,237,784

Weighted-average number of shares outstanding, diluted
 
50,333,056

 
50,499,948

 
50,599,974

 
50,590,460

 
49,925,550

 
50,015,869

 
50,618,757

 
50,237,784